vimarsana.com

Page 42 - ப்ரெஸிடெந்ஶியல் திசைமாற்றி குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nigeria Confirms First Case of Covid s Delta Variant

Onyebuchi Ezigbo in Abuja The Nigeria Centre for Disease Control (NCDC) has detected a confirmed case with the SARS-CoV-2 Delta variant, also known as lineage B.1.617.2 in Nigeria. The Delta variant is recognised by the World Health Organization (WHO) as a variant of concern, given its increased transmissibility A statement issued Thursday night by the Head of Communications at the NCDC, Dr. Yahaya Disu, said the variant was detected in a traveler to Nigeria, following the routine travel test required of all international travelers and genomic sequencing at the NCDC National Reference Laboratory, Abuja. As part of Nigeria’s COVID-19 response, NCDC said it has been working with the Nigerian

COVID-19: Nigeria confirms first cases of Delta variant

x The variant was detected in a traveller to Nigeria, following the routine travel test required of all international travellers and genomic sequencing at the NCDC National Reference Laboratory, Abuja. The Delta variant is recognised by the World Health Organization (WHO) as a variant of concern, given its increased transmissibility. The variant has been detected in over 90 countries and is expected to spread to more countries. NCDC explained that the Delta variant has been linked to a surge in cases in countries where it is the dominant strain in circulation, adding that there are ongoing studies to understand the impact of the variant on existing vaccines and therapeutics.

FG Confirms Case of Delta Variant of COVID-19 in Nigeria

Onyebuchi Ezigbo in Abuja The federal government yesterday confirmed the detection of a confirmed case of COVID-19 with the SARS-CoV-2 Delta variant, also known as lineage B.1.617.2 in Nigeria. The Delta variant is recognised by the World Health Organisation (WHO) as a variant of concern, given its increased transmissibility. The variant has been detected in over 90 countries and is expected to spread to more countries. The variant has also been linked to a surge in cases in countries where it is the dominant strain in circulation. There are ongoing studies to understand the impact of the variant on existing vaccines and therapeutics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.